Santa Cruz Biotechnology, Inc. offers a broad range of gene silencers in the form of siRNAs, shRNA Plasmids and shRNA Lentiviral Particles. DUB gene silencers are available as DUB siRNA, DUB shRNA Plasmid, DUB shRNA Lentiviral Particles. Gene silencers are useful for gene studies in combination with antibodies used for protein detection.
R indicates a highly recommended product based on customer preference.
VEJA TAMBÉM
VEJA TAMBÉM
Empty Table Header | Nome do Produto | CATALOG # | Species | Aplicacao | MARCADOR | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|---|
DUB1 siRNA (m) | sc-143185 | m | Gene Silencing | N/A | 0 | ||
DUB1 Plasmídeo shRNA (m) | sc-143185-SH | m | Gene Silencing | Puromycin | 0 | ||
DUB1 sarna (m) Partículas de lentivirus | sc-143185-V | m | Gene Silencing | Puromycin | 0 | ||
DUB1 (m)-PR | sc-143185-PR | m | Primer | N/A | 0 | ||
DUB1A siRNA (m) | sc-143186 | m | Gene Silencing | N/A | 0 | ||
DUB1A Plasmídeo shRNA (m) | sc-143186-SH | m | Gene Silencing | Puromycin | 0 | ||
DUB1A sarna (m) Partículas de lentivirus | sc-143186-V | m | Gene Silencing | Puromycin | 0 | ||
DUB1A (m)-PR | sc-143186-PR | m | Primer | N/A | 0 | ||
DUB2 siRNA (m) | sc-143187 | m | Gene Silencing | N/A | 0 | ||
DUB2 Plasmídeo shRNA (m) | sc-143187-SH | m | Gene Silencing | Puromycin | 0 | ||
DUB2 sarna (m) Partículas de lentivirus | sc-143187-V | m | Gene Silencing | Puromycin | 0 | ||
DUB2 (m)-PR | sc-143187-PR | m | Primer | N/A | 0 | ||
DUB2A siRNA (m) | sc-143188 | m | Gene Silencing | N/A | 0 | ||
DUB2A Plasmídeo shRNA (m) | sc-143188-SH | m | Gene Silencing | Puromycin | 0 | ||
DUB2A sarna (m) Partículas de lentivirus | sc-143188-V | m | Gene Silencing | Puromycin | 0 | ||
DUB2A (m)-PR | sc-143188-PR | m | Primer | N/A | 0 | ||
DUB3 siRNA (m) | sc-143189 | m | Gene Silencing | N/A | 1 | ||
DUB3 Plasmídeo shRNA (m) | sc-143189-SH | m | Gene Silencing | Puromycin | 1 | ||
DUB3 sarna (m) Partículas de lentivirus | sc-143189-V | m | Gene Silencing | Puromycin | 1 | ||
DUB3 (m)-PR | sc-143189-PR | m | Primer | N/A | 1 |